HOUSTON, March 08, 2017 -- VAALCO Energy, Inc. (NYSE:EGY) today announced that it will issue its fourth quarter and full year 2016 earnings release on Monday, March 13 after the close of trading and host a conference call to discuss fourth quarter and full year 2016 financial and operational results on Tuesday morning, March 14 at 8:00 a.m. Central Time (9:00 a.m. Eastern Time.)
Interested parties may participate by dialing (844) 841-1668. International parties may dial (661) 378-9859. The confirmation code is 77612453. This call will also be webcast on VAALCO’s website at www.vaalco.com.
An audio replay will be available beginning approximately two hours after the end of the call and be available through March 21, 2017 by dialing (855) 859-2056. International parties may dial (404) 537-3406. The confirmation code is 77612453.
About VAALCO
VAALCO Energy, Inc. is a Houston-based independent energy company principally engaged in the acquisition, development and production of crude oil. The Company's properties and acreage are located primarily in Gabon and Equatorial Guinea in West Africa.
Investor Contacts Elizabeth Prochnow 713-623-0801


Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



